Aeterna Zentaris Inc. - rebound?
Seite 66 von 90 Neuester Beitrag: 24.04.21 23:53 | ||||
Eröffnet am: | 20.09.15 12:53 | von: captain_ahab | Anzahl Beiträge: | 3.232 |
Neuester Beitrag: | 24.04.21 23:53 | von: Katjakbxia | Leser gesamt: | 297.157 |
Forum: | Hot-Stocks | Leser heute: | 24 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 63 | 64 | 65 | | 67 | 68 | 69 | ... 90 > |
Das kann auch nochmal kurz abtauchen, denn jetzt müßen sie dann um jeden Preis werfen, wenn der Plan aufgehen will und die bis Freitag die B-Warrants gewandelt haben wollen. Das rumpelt noch mal richtig bzw. kann nochmal richtig rumpeln....nur meine Meinung.
AEterna Zentaris Aktie & Unternehmen
Branche Pharmazie
Herkunft Kanada
Website www.aezsinc.com
Indizes/Listen Meistgesuchte Aktien, NASDAQ
Aktienanzahl 632,7 Mio. (Stand: 09.11.15)
Marktkap. 36,7 Mio. €
Die warten so lange bis nach dem Split, dann können Sie ja zu 1-2 $ verkaufen.
LOL
und da habe beide gute Chancen recht zu behalten.
http://www.newsoracle.com/...iconix-brand-group-inc-nasdaqicon/13041/
Auszug aus der Meldung ......
AEterna Zentaris Inc. price gained 19.60% during the week, closing last trade up 4.91% at $0.06. Its average EPS growth rate seen in the last 5 fiscal years is 30.40%. The company expects next year’s EPS growth to equal 45.20%. The stock price is below by -81.33% versus the average price over the last 200 days. Aeterna Zentaris Inc. (AEZS) (AEZ.TO) (the “Company”), a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women’s health, on November 5, 2015 reported financial and operating results as at and for the third quarter ended September 30, 2015. Selling expenses were $1.7 million for the three-month period ended September 30, 2015, as compared to $0.9 million for the same period in 2014. This increase is mainly attributable to the implementation of our promotional activities associated with EstroGel®, which commenced in late 2014. We also expanded the size of our contracted sales force from 19 to 23 sales representatives during the quarter in order to support our promotional efforts associated with Saizen®.
http://www.streetregister.com/...f-california-inc-nasdaqpacb/2510452/